vs
BioRestorative Therapies, Inc.（BRTX）与费森尤斯医疗（FMS）财务数据对比。点击上方公司名可切换其他公司
费森尤斯医疗的季度营收约是BioRestorative Therapies, Inc.的279344.5倍（$5.5B vs $19.6K）。费森尤斯医疗净利率更高（7.9% vs -16365.5%，领先16373.4%）。费森尤斯医疗同比增速更快（-0.3% vs -54.7%）
BioRestorative Therapies, Inc.是一家临床阶段生物技术企业，专注于创新再生医学疗法的研发，核心管线覆盖慢性腰痛、代谢类疾病等未被满足的医疗需求领域，主要面向北美市场，推进细胞类创新候选治疗产品的临床开发工作。
费森尤斯医疗是德国知名医疗保健企业，核心业务为肾脏透析服务，在全球运营4171家门诊透析中心，服务约34.54万名患者。公司主要为终末期肾病患者提供治疗服务，该类患者需终身每周接受3次透析治疗以维持生命。
BRTX vs FMS — 直观对比
营收规模更大
FMS
是对方的279344.5倍
$19.6K
营收增速更快
FMS
高出54.4%
-54.7%
净利率更高
FMS
高出16373.4%
-16365.5%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $19.6K | $5.5B |
| 净利润 | $-3.2M | $434.2M |
| 毛利率 | 91.7% | 27.4% |
| 营业利润率 | -19516.8% | 11.7% |
| 净利率 | -16365.5% | 7.9% |
| 营收同比 | -54.7% | -0.3% |
| 净利润同比 | -96.0% | 240.4% |
| 每股收益（稀释后） | $-0.31 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BRTXFMS
| Q4 25 | $19.6K | $5.5B | ||
| Q3 25 | $11.8K | — | ||
| Q2 25 | $303.3K | — | ||
| Q1 25 | $25.0K | — | ||
| Q4 24 | $43.3K | $5.5B | ||
| Q3 24 | $233.6K | — | ||
| Q2 24 | $89.1K | — | ||
| Q1 24 | $35.0K | — |
净利润BRTXFMS
| Q4 25 | $-3.2M | $434.2M | ||
| Q3 25 | $-3.0M | — | ||
| Q2 25 | $-2.7M | — | ||
| Q1 25 | $-5.3M | — | ||
| Q4 24 | $-1.6M | $127.6M | ||
| Q3 24 | $-1.1M | — | ||
| Q2 24 | $-4.0M | — | ||
| Q1 24 | $-2.2M | — |
毛利率BRTXFMS
| Q4 25 | 91.7% | 27.4% | ||
| Q3 25 | 10.4% | — | ||
| Q2 25 | 97.1% | — | ||
| Q1 25 | 88.4% | — | ||
| Q4 24 | 92.3% | 25.0% | ||
| Q3 24 | 92.2% | — | ||
| Q2 24 | 92.7% | — | ||
| Q1 24 | 100.0% | — |
营业利润率BRTXFMS
| Q4 25 | -19516.8% | 11.7% | ||
| Q3 25 | -31432.3% | — | ||
| Q2 25 | -1089.8% | — | ||
| Q1 25 | -19230.1% | — | ||
| Q4 24 | -6212.8% | 5.1% | ||
| Q3 24 | -979.0% | — | ||
| Q2 24 | -2770.8% | — | ||
| Q1 24 | -11740.7% | — |
净利率BRTXFMS
| Q4 25 | -16365.5% | 7.9% | ||
| Q3 25 | -25748.1% | — | ||
| Q2 25 | -875.8% | — | ||
| Q1 25 | -21359.2% | — | ||
| Q4 24 | -3778.6% | 2.3% | ||
| Q3 24 | -467.2% | — | ||
| Q2 24 | -4521.4% | — | ||
| Q1 24 | -6352.2% | — |
每股收益（稀释后）BRTXFMS
| Q4 25 | $-0.31 | — | ||
| Q3 25 | $-0.33 | — | ||
| Q2 25 | $-0.30 | — | ||
| Q1 25 | $-0.64 | — | ||
| Q4 24 | $-0.20 | — | ||
| Q3 24 | $-0.13 | — | ||
| Q2 24 | $-0.50 | — | ||
| Q1 24 | $-0.33 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.0M | $1.7B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $356.7K | $15.4B |
| 总资产 | $4.1M | $33.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BRTXFMS
| Q4 25 | $3.0M | $1.7B | ||
| Q3 25 | $4.5M | — | ||
| Q2 25 | $7.4M | — | ||
| Q1 25 | $9.1M | — | ||
| Q4 24 | $10.7M | $1.3B | ||
| Q3 24 | $13.1M | — | ||
| Q2 24 | $14.7M | — | ||
| Q1 24 | $16.4M | — |
股东权益BRTXFMS
| Q4 25 | $356.7K | $15.4B | ||
| Q3 25 | $2.2M | — | ||
| Q2 25 | $4.8M | — | ||
| Q1 25 | $6.1M | — | ||
| Q4 24 | $8.5M | $17.0B | ||
| Q3 24 | $10.0M | — | ||
| Q2 24 | $10.8M | — | ||
| Q1 24 | $14.5M | — |
总资产BRTXFMS
| Q4 25 | $4.1M | $33.5B | ||
| Q3 25 | $5.6M | — | ||
| Q2 25 | $8.5M | — | ||
| Q1 25 | $10.3M | — | ||
| Q4 24 | $12.3M | $36.3B | ||
| Q3 24 | $14.6M | — | ||
| Q2 24 | $16.1M | — | ||
| Q1 24 | $18.0M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.4M | $2.9B |
| 自由现金流经营现金流 - 资本支出 | $-2.5M | — |
| 自由现金流率自由现金流/营收 | -12728.8% | — |
| 资本支出强度资本支出/营收 | 406.5% | — |
| 现金转化率经营现金流/净利润 | — | 6.67× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流BRTXFMS
| Q4 25 | $-2.4M | $2.9B | ||
| Q3 25 | $-2.9M | — | ||
| Q2 25 | $-2.7M | — | ||
| Q1 25 | $-2.8M | — | ||
| Q4 24 | $-2.3M | $2.6B | ||
| Q3 24 | $-1.7M | — | ||
| Q2 24 | $-1.9M | — | ||
| Q1 24 | $-2.3M | — |
自由现金流BRTXFMS
| Q4 25 | $-2.5M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $-2.8M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-1.8M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率BRTXFMS
| Q4 25 | -12728.8% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -11260.7% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -752.6% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度BRTXFMS
| Q4 25 | 406.5% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 145.6% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 25.0% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率BRTXFMS
| Q4 25 | — | 6.67× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 20.20× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
